The PE Ratio as of December 2024 (TTM) for Alterity Therapeutics Limited (PRNAF) is -0.36

According to Alterity Therapeutics Limited’s latest financial reports and current stock price. The company's current PE Ratio is -0.36. This represents a change of 10.92% compared to the average of -0.32 of the last 4 quarters.

Alterity Therapeutics Limited (PRNAF) Historical PE Ratio (quarterly & annually)

How has PRNAF PE Ratio performed in the past?

The mean historical PE Ratio of Alterity Therapeutics Limited over the last ten years is -3.70. The current -0.36 PE Ratio has changed 873.09% with respect to the historical average. Over the past ten years (40 quarters), PRNAF's PE Ratio was at its highest in in the March 2021 quarter at 0. The PE Ratio was at its lowest in in the September 2014 quarter at -45.86.

Alterity Therapeutics Limited (PRNAF) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Alterity Therapeutics Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Alterity Therapeutics Limited (PRNAF) Average PE Ratio

How has PRNAF PE Ratio performed in the past?

The current PE Ratio of Alterity Therapeutics Limited (PRNAF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Alterity Therapeutics Limited (PRNAF) PE Ratio vs. Peers

How is PRNAF’s PE Ratio compared to its peers?

Alterity Therapeutics Limited’s PE Ratio is less than Genprex, Inc. (-0.14), greater than Reviva Pharmaceuticals Holdings, Inc. (-1.85), greater than Greenwich LifeSciences, Inc. (-15.20), greater than Cognition Therapeutics, Inc. (-0.84), greater than Gracell Biotechnologies Inc. (-29.26), less than Galectin Therapeutics Inc. (0), greater than Northwest Biotherapeutics, Inc. (-1.24), greater than CEL-SCI Corporation (-4.66), greater than Tonix Pharmaceuticals Holding Corp. (-1.38), less than Jaguar Health, Inc. (-0.17), less than Acasti Pharma Inc. (-0.26), greater than Diffusion Pharmaceuticals Inc. (-3.10), greater than iBio, Inc. (-1.66), greater than Vaxart, Inc. (-0.92), greater than Novavax, Inc. (-1.95), greater than Ocugen, Inc. (-4.74), greater than CohBar, Inc. (-4.47), less than Rain Therapeutics Inc. (-0.13), greater than Viking Therapeutics, Inc. (-1.51), greater than TG Therapeutics, Inc. (-47.87), greater than X4 Pharmaceuticals, Inc. (-328.06), greater than PDS Biotechnology Corporation (-8.94), greater than Madrigal Pharmaceuticals, Inc. (-1.52), greater than null (-13.10),

Build a custom stock screener for Alterity Therapeutics Limited (PRNAF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Alterity Therapeutics Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Alterity Therapeutics Limited (PRNAF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Alterity Therapeutics Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.